Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 7
1987 14
1988 29
1989 58
1990 48
1991 54
1992 67
1993 68
1994 93
1995 108
1996 112
1997 76
1998 97
1999 113
2000 82
2001 69
2002 56
2003 59
2004 53
2005 45
2006 43
2007 56
2008 56
2009 52
2010 42
2011 46
2012 43
2013 33
2014 30
2015 28
2016 15
2017 10
2018 6
2019 3
2020 4
2021 7
2022 6
2023 3
2024 10
2025 5
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,751 results

Results by year

Filters applied: . Clear all
Page 1
Zidovudine (Retrovir) update.
Rachlis AR. Rachlis AR. CMAJ. 1990 Dec 1;143(11):1177-85. CMAJ. 1990. PMID: 2224694 Free PMC article. Review.
Zidovudine (AZT) is the first antiretroviral agent to be licensed for the treatment of human immunodeficiency virus (HIV) infection. ...After a search of MEDLINE for pertinent articles published since 1985, controlled studies and studies of long-term zidovudine ther …
Zidovudine (AZT) is the first antiretroviral agent to be licensed for the treatment of human immunodeficiency virus (HIV) infection. …
Azidothymidine.
Oksenhendler E. Oksenhendler E. Nouv Rev Fr Hematol (1978). 1989;31(2):69-72. Nouv Rev Fr Hematol (1978). 1989. PMID: 2671931 Review.
Zidovudine (AZT).
[No authors listed] [No authors listed] Lancet. 1987 Apr 25;1(8539):957-8. Lancet. 1987. PMID: 2882345 Clinical Trial. No abstract available.
Probenecid and zidovudine metabolism.
Kornhauser DM, Petty BG, Hendrix CW, Woods AS, Nerhood LJ, Bartlett JG, Lietman PS. Kornhauser DM, et al. Lancet. 1989 Aug 26;2(8661):473-5. doi: 10.1016/s0140-6736(89)92087-4. Lancet. 1989. PMID: 2570186 Free article. Clinical Trial.
Zidovudine plasma concentrations were measured while subjects were receiving zidovudine alone, after 3 days of zidovudine plus 500 mg probenecid every 8 h, and after 3 days of zidovudine plus 500 mg probenecid plus 260 mg quinine sulphate every 8 h. .. …
Zidovudine plasma concentrations were measured while subjects were receiving zidovudine alone, after 3 days of zidovudine …
Lessons from the Concorde trial.
Peto T, Darbyshire J. Peto T, et al. Br J Hosp Med. 1994 Oct 19-Nov 1;52(8):378-9. Br J Hosp Med. 1994. PMID: 7858826 Clinical Trial. No abstract available.
Concorde remains aloft.
[No authors listed] [No authors listed] Lancet. 1989 Oct 28;2(8670):1017-8. Lancet. 1989. PMID: 2572744 Clinical Trial. No abstract available.
Retrovir trial.
Lehrman SN. Lehrman SN. Ann Emerg Med. 1989 Mar;18(3):330. doi: 10.1016/s0196-0644(89)80437-8. Ann Emerg Med. 1989. PMID: 2647003 Clinical Trial. No abstract available.
Half-dose zidovudine.
de Truchis P, Salmon D, Matheron S, Jelasko P, Rozenbaum W, Leport C. de Truchis P, et al. Lancet. 1991 May 4;337(8749):1109. doi: 10.1016/0140-6736(91)91766-n. Lancet. 1991. PMID: 1673539 Clinical Trial. No abstract available.
Zidovudine and other drugs against HIV.
[No authors listed] [No authors listed] Drug Ther Bull. 1988 Dec 28;26(26):101-4. Drug Ther Bull. 1988. PMID: 3065024 Review. No abstract available.
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS. D'Aquila RT, et al. Ann Intern Med. 1996 Jun 15;124(12):1019-30. doi: 10.7326/0003-4819-124-12-199606150-00001. Ann Intern Med. 1996. PMID: 8633815 Clinical Trial.
OBJECTIVE: To study the addition of a third human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, nevirapine, to the combination of zidovudine and didanosine. DESIGN: A 48-week, randomized, double-blind, placebo-controlled trial at 16 AIDS (acquired …
OBJECTIVE: To study the addition of a third human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, nevirapine, to the …
1,751 results